Min-Jeong Kim Selected Research

Keratitis

4/2022	Specific Detection of Acanthamoeba species using Polyclonal Peptide Antibody Targeting the Periplasmic Binding Protein of A. castellanii.
2/2022	Characterization of a Peptide Antibody Specific to the Adenylyl Cyclase-Associated Protein of Acanthamoeba castellanii.
1/2021	Chorismate mutase peptide antibody enables specific detection of Acanthamoeba.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Min-Jeong Kim Research Topics

Disease

10	Alzheimer Disease (Alzheimer's Disease) 03/2023 - 03/2008
9	Neoplasms (Cancer) 03/2023 - 12/2003
7	Inflammation (Inflammations) 09/2023 - 04/2009
6	Infections 01/2023 - 11/2009
6	Stomach Neoplasms (Stomach Cancer) 11/2022 - 02/2009
5	Cognitive Dysfunction 12/2022 - 02/2009
4	Cysts 03/2023 - 01/2022
4	Hypertension (High Blood Pressure) 02/2023 - 01/2008
4	Neuroinflammatory Diseases 02/2021 - 05/2020
3	Type 2 Diabetes Mellitus (MODY) 01/2024 - 02/2022
3	Obesity 07/2023 - 01/2018
3	Acanthamoeba Keratitis 03/2023 - 01/2022
3	Keratitis 04/2022 - 01/2021
3	Adenocarcinoma 01/2021 - 04/2016
3	Rectal Neoplasms (Rectal Cancer) 10/2016 - 05/2013
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2013 - 12/2009
2	Vascular Calcification 01/2024 - 01/2020
2	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 01/2015
2	Atopic Dermatitis (Atopic Eczema) 09/2023 - 10/2022
2	Parasitic Diseases (Parasitic Disease) 03/2023 - 11/2022
2	Hemorrhage 05/2022 - 12/2020
2	Body Weight (Weight, Body) 02/2022 - 08/2015
2	Rheumatoid Arthritis 05/2020 - 05/2017
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 04/2018
2	Insulin Resistance 01/2020 - 01/2018
2	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 07/2014
2	Hypersensitivity (Allergy) 12/2016 - 01/2016
2	Disease Progression 10/2016 - 02/2007
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2016 - 03/2013
2	Parkinson Disease (Parkinson's Disease) 03/2013 - 10/2008
2	Ganglion Cysts (Ganglion) 09/2010 - 09/2006
1	Adenoma (Adenomas) 01/2024
1	Retroperitoneal Fibrosis 12/2023
1	Autoimmune Pancreatitis 12/2023
1	Margins of Excision 11/2023
1	Uterine Cervical Dysplasia 11/2023
1	Virus Diseases (Viral Diseases) 07/2023
1	Drowning 07/2023
1	Hypoxia (Hypoxemia) 07/2023
1	Breast Neoplasms (Breast Cancer) 06/2023
1	Overweight 06/2023
1	Gallstones (Gallstone) 04/2023
1	Cholelithiasis 04/2023

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 07/2023 - 07/2013
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2008
6	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018 - 10/2009
5	HCEIBA 03/2023 - 01/2021
4	EnzymesIBA 07/2023 - 05/2020
4	Amyloid (Amyloid Fibrils)IBA 12/2022 - 03/2008
4	Docetaxel (Taxotere)FDA Link 04/2016 - 02/2009
3	Phosphates (Orthophosphate)IBA 01/2024 - 05/2013
3	VaccinesIBA 07/2023 - 11/2009
3	AntibodiesIBA 03/2023 - 04/2022
3	Peptides (Polypeptides)IBA 03/2023 - 01/2021
3	LipopolysaccharidesIBA 01/2023 - 10/2018
3	Therapeutic UsesIBA 01/2021 - 01/2016
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2018 - 01/2016
3	CalciumIBA 12/2009 - 10/2007
3	Translationally-Controlled 1 Tumor ProteinIBA 12/2009 - 01/2008
2	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 12/2020
2	Glucagon-Like Peptide-1 ReceptorIBA 01/2024 - 02/2022
2	dulaglutideIBA 01/2024 - 02/2022
2	Exenatide (Byetta)FDA Link 01/2024 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 09/2023 - 10/2022
2	Dinitrochlorobenzene (DNCB)IBA 09/2023 - 10/2022
2	SaponinsIBA 03/2023 - 01/2021
2	Polysaccharides (Glycans)IBA 03/2023 - 01/2021
2	CytokinesIBA 11/2022 - 10/2022
2	Hormones (Hormone)IBA 06/2022 - 01/2020
2	Gemcitabine FDA Link 01/2021 - 04/2015
2	tanshinoneIBA 01/2018 - 07/2014
2	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 01/2016
2	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2018 - 07/2014
2	Bee Venoms (Bee Venom)IBA 12/2016 - 01/2016
2	S 1 (combination)IBA 04/2016 - 04/2015
2	11-octadecenoic acid (vaccenic acid)IBA 01/2016 - 08/2015
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 09/2010 - 09/2006
2	Adenosine Triphosphatases (ATPase)IBA 12/2009 - 01/2008
2	Phosphotransferases (Kinase)IBA 03/2008 - 12/2003
1	Calcibiotic Root Canal SealerIBA 01/2024
1	SodiumIBA 01/2024
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2024
1	Liraglutide FDA Link 01/2024
1	Capsules (Microcapsules)IBA 12/2023
1	Lugol's solution (Lugol's iodine)IBA 11/2023
1	Proton Pump InhibitorsIBA 11/2023
1	Recombinant ProteinsIBA 07/2023
1	Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA 07/2023
1	Mitogen-Activated Protein Kinase 3IBA 07/2023
1	CholesterolIBA 06/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2023

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 01/2021 - 10/2009
6	Therapeutics 12/2020 - 12/2009
3	Radiotherapy 06/2023 - 08/2016
3	Contact Lenses 03/2023 - 01/2022
3	Chemoradiotherapy 10/2016 - 05/2013
2	Oral Administration 12/2022 - 02/2021
2	Liver Transplantation 08/2011 - 03/2007
2	Neoadjuvant Therapy 08/2011 - 12/2009
1	Ambulatory Care (Outpatient Care) 04/2023